应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MORF Morphic Holding, Inc.
停牌 12-23 05:05:58 EST
56.99
+0.00
0.00%
最高
56.99
最低
56.99
成交量
0.00
今开
56.99
昨收
56.99
日振幅
0.00%
总市值
28.62亿
流通市值
19.43亿
总股本
5,022万
成交额
1.02亿
换手率
0.00%
流通股本
3,409万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
加拿大皇家银行：重申Morphic Holding(MORF.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由57.
智通财经 · 07-26
加拿大皇家银行：重申Morphic Holding(MORF.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由57.
Stifel：维持Morphic Holding(MORF.US)评级，由持有调整至持有评级, 目标价由30.00美元调整至57.
智通财经 · 07-22
Stifel：维持Morphic Holding(MORF.US)评级，由持有调整至持有评级, 目标价由30.00美元调整至57.
美国研究综述-Armada Hoffler Properties、Morphic Holding、Solid Biosciences
Reuters · 07-15
美国研究综述-Armada Hoffler Properties、Morphic Holding、Solid Biosciences
TD Cowen：下调Morphic Holding(MORF.US)评级，由买入调整至持有评级。
智通财经 · 07-10
TD Cowen：下调Morphic Holding(MORF.US)评级，由买入调整至持有评级。
加拿大皇家银行：下调Morphic Holding(MORF.US)评级，由优于大市调整至与大盘持平评级, 目标价由70.
智通财经 · 07-09
加拿大皇家银行：下调Morphic Holding(MORF.US)评级，由优于大市调整至与大盘持平评级, 目标价由70.
昨夜暴涨75%！这则收购牵涉6万亿巨头的重磅布局
券商中国 · 07-09
昨夜暴涨75%！这则收购牵涉6万亿巨头的重磅布局
Morphic暴涨超75%，获礼来以57美元/股的价格现金收购
智通财经网 · 07-08
Morphic暴涨超75%，获礼来以57美元/股的价格现金收购
【美股异动 | 获礼来(LLY.US)溢价收购 Morphic(MORF.US)涨超75% 】智通财经获悉，周一，Morphic(MORF.
智通财经 · 07-08
【美股异动 | 获礼来(LLY.US)溢价收购 Morphic(MORF.US)涨超75% 】智通财经获悉，周一，Morphic(MORF.
Morphic Holding, Inc.盘中异动 早盘股价大涨75.22%
自选股智能写手 · 07-08
Morphic Holding, Inc.盘中异动 早盘股价大涨75.22%
美股异动丨Morphic盘前暴涨76%，获礼来溢价79%收购Morphic(MORF.US)盘前大涨超76%报56.1美元。
格隆汇 · 07-08
美股异动丨Morphic盘前暴涨76%，获礼来溢价79%收购Morphic(MORF.US)盘前大涨超76%报56.1美元。
礼来(LLY)将收购美国生物制药公司Morphic(MORF) 涉资约32亿美元
金吾财讯 · 07-08
礼来(LLY)将收购美国生物制药公司Morphic(MORF) 涉资约32亿美元
Morphic(MORF.US)盘前大涨近80% 获礼来(LLY.US)溢价收购
智通财经网 · 07-08
Morphic(MORF.US)盘前大涨近80% 获礼来(LLY.US)溢价收购
【Morphic(MORF.US)盘前大涨近80% 获礼来(LLY.US)溢价收购】智通财经APP获悉，为加强免疫学产品线，礼来(LLY.
智通财经 · 07-08
【Morphic(MORF.US)盘前大涨近80% 获礼来(LLY.US)溢价收购】智通财经APP获悉，为加强免疫学产品线，礼来(LLY.
更新版 1-礼来以 32 亿美元收购肠道疾病药物开发商 Morphic
Reuters · 07-08
更新版 1-礼来以 32 亿美元收购肠道疾病药物开发商 Morphic
BUZZ-莫菲克控股公司因礼来公司收购交易而大涨
Reuters · 07-08
BUZZ-莫菲克控股公司因礼来公司收购交易而大涨
礼来公司将以 32 亿美元收购 Morphic 控股公司
Reuters · 07-08
礼来公司将以 32 亿美元收购 Morphic 控股公司
将被礼来收购？生物制药公司Morphic盘前涨超75%
老虎资讯综合 · 07-08
将被礼来收购？生物制药公司Morphic盘前涨超75%
Morphic Holding, Inc.盘中异动 大幅下挫5.20%报32.30美元
自选股智能写手 · 07-01
Morphic Holding, Inc.盘中异动 大幅下挫5.20%报32.30美元
Morphic Holding, Inc.盘中异动 下午盘大幅上涨5.02%
自选股智能写手 · 06-28
Morphic Holding, Inc.盘中异动 下午盘大幅上涨5.02%
Morphic Holding, Inc.盘中异动 快速下挫5.22%报31.77美元
自选股智能写手 · 06-26
Morphic Holding, Inc.盘中异动 快速下挫5.22%报31.77美元
暂无数据
公司概况
公司名称：
Morphic Holding, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Morphic Holding, Inc.于2014年8月根据特拉华州法律成立。他们是一家生物制药公司，将其专有的见解应用于整合素，以发现和开发可能是一流的口服小分子整合素治疗药物。整合素是具有多种批准的可注射重磅炸弹药物的目标类别，用于治疗严重的慢性疾病，包括自身免疫，心血管和代谢疾病，纤维化和癌症。他们利用他们对整合素结构和生物学的独特理解，创建了Morphic整合素技术平台或MInT平台，以开发新的候选产品，旨在实现口服给药所需的效力，高选择性和药物性质。
发行价格：
--
{"stockData":{"symbol":"MORF","market":"US","secType":"STK","nameCN":"Morphic Holding, Inc.","latestPrice":56.99,"timestamp":1723752000000,"preClose":56.99,"halted":3,"volume":0,"delay":0,"floatShares":34093083,"shares":50224699,"eps":-3.843083,"marketStatus":"停牌","marketStatusCode":1,"change":0,"latestTime":"12-23 05:05:58 EST","open":56.99,"high":56.99,"low":56.99,"amount":102339953.0986,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.843083,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1561608000000,"adjPreClose":56.99,"volumeRatio":0},"requestUrl":"/m/hq/s/MORF/tweets","defaultTab":"tweets","newsList":[{"id":"2454340376","title":"加拿大皇家银行：重申Morphic Holding(MORF.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由57.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454340376","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454340376?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:37","pubTimestamp":1722001060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","MORF"],"gpt_icon":0},{"id":"2453976429","title":"Stifel：维持Morphic Holding(MORF.US)评级，由持有调整至持有评级, 目标价由30.00美元调整至57.","url":"https://stock-news.laohu8.com/highlight/detail?id=2453976429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453976429?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:30","pubTimestamp":1721651426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","MORF"],"gpt_icon":0},{"id":"2451694902","title":"美国研究综述-Armada Hoffler Properties、Morphic Holding、Solid Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2451694902","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451694902?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:19","pubTimestamp":1721027985,"startTime":"0","endTime":"0","summary":" 路透7月15日 - 华尔街证券分析师周一调整了对 Armada Hoffler Properties、Morphic Holding 和 Solid Biosciences 等几家美国上市公司的评级和目标价。要点 * Armada Hoffler Properties Inc ：杰富瑞将其评级从 \"买入 \"下调至 \"持有 * Morphic Holding Inc ：杰富瑞将其评级从 \"买入 \"下调至 \"持有 * Solid Biosciences Inc ：摩根大通将其评级从中性上调至增持 * Valero Energy Corp ：杰富瑞将目标价从184美元上调至191美元 * 富国银行 ：杰富瑞将目标价从 64 美元下调至 62 美元 以下是路透周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EA","ULTA","RNGR","SLDB","BLK","LU1917777945.USD","PTEN","BK4548","BX","LU0098860793.USD","LU1668664300.SGD","LU2237443978.SGD","LU1366192091.USD","LU2456880835.USD","ACDC","NRIX","SLB","CLB","LU1720051017.SGD","SND","LU1670628061.USD","OIS","WHD","LU2023250843.SGD","HAL","LEGN","WRB","AESI","VLO","BK","CHX","MPC","TTD","LU0011850046.USD","LU0149725797.USD","WMB","CVNA","NOV","LBRT","LU2505996509.AUD","MORF","TAP","KLXE","AHH","BKR","BK4107","HP","LU1244550221.USD","IE00BKVL7J92.USD","LU2505996681.GBP"],"gpt_icon":0},{"id":"2450020163","title":"TD Cowen：下调Morphic Holding(MORF.US)评级，由买入调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450020163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450020163?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:28","pubTimestamp":1720542483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4566","TD","BK4207","BK4139","MORF"],"gpt_icon":0},{"id":"2450043519","title":"加拿大皇家银行：下调Morphic Holding(MORF.US)评级，由优于大市调整至与大盘持平评级, 目标价由70.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450043519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450043519?lang=zh_cn&edition=full","pubTime":"2024-07-09 19:28","pubTimestamp":1720524527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","MORF"],"gpt_icon":0},{"id":"2449094997","title":"昨夜暴涨75%！这则收购牵涉6万亿巨头的重磅布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2449094997","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449094997?lang=zh_cn&edition=full","pubTime":"2024-07-09 07:13","pubTimestamp":1720480427,"startTime":"0","endTime":"0","summary":"暴涨75%北京时间7月8日晚间，美股开盘后，美国生物制药公司Morphic股价一度暴涨超75%。消息面上，礼来公司同意以约32亿美元收购Morphic Holding Inc.，以获得治疗炎症性肠病和其他慢性疾病的实验性疗法。该交易已获得两家公司董事会的批准，该交易不受任何融资条件的约束，预计将于2024年第三季度完成。据悉，溃疡性结肠炎大约有数百万的患者，会严重影响到患者的生活品质。本次获批用于治疗成人2型糖尿病患者血糖控制。","market":"us","thumbnail":"https://static.tigerbbs.com/532b4e31876245e0890df4db6bf8baf5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/532b4e31876245e0890df4db6bf8baf5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3NjM5MjIwOQ==&mid=2652163419&idx=1&sn=2afb0a974bde25eb147dd6f2e8ca2621&chksm=8598eca7d1334dfe3dc1ad928217f5b4dc8105029926058ed60ab86ee81af9775fa119174037&scene=0#rd","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","MORF"],"gpt_icon":1},{"id":"2449315704","title":"Morphic暴涨超75%，获礼来以57美元/股的价格现金收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2449315704","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449315704?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:57","pubTimestamp":1720450666,"startTime":"0","endTime":"0","summary":"礼来公司高溢价收购Morphic的主要意图，或许是为了加码IBD(炎症性肠病)赛道。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147406.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LLY","MORF"],"gpt_icon":0},{"id":"2449043767","title":"【美股异动 | 获礼来(LLY.US)溢价收购 Morphic(MORF.US)涨超75% 】智通财经获悉，周一，Morphic(MORF.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449043767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449043767?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:57","pubTimestamp":1720450666,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["161726","LU1551013425.SGD","LU0097036916.USD","LU1280957306.USD","LU0385154629.USD","LU0466842654.USD","IE00B2B36J28.USD","LU2237443978.SGD","IE00BFTCPJ56.SGD","LU2237443549.SGD","LU0061475181.USD","LU0122379950.USD","LU1623119135.USD","LU2491050071.SGD","LU0456855351.SGD","LU0640476718.USD","LU1064131342.USD","LU1712237335.SGD","LU1551013342.USD","LU1804176565.USD","LU2237443382.USD","LU0689472784.USD","LU1057294990.SGD","LU0882574055.USD","LU0943347566.SGD","IE00BJT1NW94.SGD","LU1988902786.USD","LU0672654240.SGD","LU0109391861.USD","IE0004445239.USD","LU2491049909.HKD","LU2265009873.SGD","BK4588","399441","BK4533","LU0238689110.USD","MORF","LU0058720904.USD","LU0079474960.USD","BK4585","LU1814569148.SGD","BK4139","BK4581","LU1267930730.SGD","LU2237438978.USD","BK4534","LLY","LU0256863811.USD","LU2237443622.USD"],"gpt_icon":0},{"id":"2449705358","title":"Morphic Holding, Inc.盘中异动 早盘股价大涨75.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449705358","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449705358?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445478,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，Morphic Holding, Inc.股票出现异动，股价急速上涨75.22%。Morphic Holding, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Morphic Holding, Inc.公司简介：Morphic Holding Inc是一家生物制药公司，将其对整合素的见解应用于发现和开发口服小分子整合素治疗药物的管道。交易宣布后，Morphic Holding股价盘前大涨近80%。根据协议，礼来将发起要约收购，以收购Morphic所有流通股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131199f1ee733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131199f1ee733&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MORF"],"gpt_icon":0},{"id":"2449377136","title":"美股异动丨Morphic盘前暴涨76%，获礼来溢价79%收购Morphic(MORF.US)盘前大涨超76%报56.1美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449377136","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449377136?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:57","pubTimestamp":1720439845,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0198837287.USD","LU0672654240.SGD","IE00B2B36J28.USD","BK4585","LU0109391861.USD","LU0471298777.SGD","LU2237443978.SGD","MORF","LU1267930730.SGD","IE00B1BXHZ80.USD","LU0882574139.USD","LU0882574055.USD","BK4588","LU0417517546.SGD","LU2491049909.HKD","IE0004445239.USD","LLY","IE00BJT1NW94.SGD","LU0079474960.USD","LU1023059063.AUD","LU0640476718.USD","LU0820561818.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4581","BK4139","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1623119135.USD","LU0943347566.SGD","LU1551013425.SGD","LU2237443622.USD","LU0238689110.USD","LU0122379950.USD","LU0256863811.USD","LU2237438978.USD","LU2491050071.SGD","IE0009355771.USD","LU1712237335.SGD","LU1280957306.USD","LU0097036916.USD","LU1804176565.USD","LU0385154629.USD","GB00BDT5M118.USD","LU0466842654.USD","BK4007","LU2237443549.SGD","LU2468319806.SGD","BK4534","LU2264538146.SGD"],"gpt_icon":0},{"id":"2449061779","title":"礼来(LLY)将收购美国生物制药公司Morphic(MORF) 涉资约32亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449061779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449061779?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:45","pubTimestamp":1720439102,"startTime":"0","endTime":"0","summary":"金吾财讯 | 礼来(LLY)同意以约32亿美元收购美国生物制药公司Morphic Holding Inc.(MORF)，以获取治疗炎症性肠病和其他慢性疾病的实验性疗法。礼来将以每股57美元的价格收购位于马萨诸塞州沃尔瑟姆的Morphic，这比上周五的收盘价高出79%，两家公司在周一的一份声明中表示。Morphic的董事会建议股东接受这一要约。Morphic正在开发一种所谓的选择性口服小分子抑制剂，用于治疗炎症性肠病。这种实验性疗法目前正在两项中期研究中评估溃疡性结肠炎，并在一项早期试验中评估克罗恩病。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/MWQzMTFhODQyN2JiYzIyN2I5NDJhMjljMWNiNDgxMjMwMDQxMDc4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/MWQzMTFhODQyN2JiYzIyN2I5NDJhMjljMWNiNDgxMjMwMDQxMDc4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277519","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2237443549.SGD","LU1023059063.AUD","LU0097036916.USD","LU2491050071.SGD","LU1057294990.SGD","LU0466842654.USD","LU0820561818.USD","LU0385154629.USD","LU0882574139.USD","LU0820561909.HKD","LU0471298777.SGD","LU1267930730.SGD","LU0417517546.SGD","BK4581","LU0943347566.SGD","LU0109391861.USD","BK4588","LU2237438978.USD","LU2491049909.HKD","LU2468319806.SGD","LU0198837287.USD","LU2265009873.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU1814569148.SGD","LU0689472784.USD","LU1064131342.USD","MORF","LU2237443978.SGD","LU0456855351.SGD","LU1988902786.USD","LU1804176565.USD","LU2237443382.USD","LU0320765059.SGD","IE00B1BXHZ80.USD","LU0640476718.USD","LU0114720955.EUR","LU1623119135.USD","LU0672654240.SGD","LU0289739699.SGD","LU0238689110.USD","IE0009355771.USD","LU2237443622.USD","BK4585","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1712237335.SGD","LLY","LU0079474960.USD"],"gpt_icon":0},{"id":"2449776517","title":"Morphic(MORF.US)盘前大涨近80% 获礼来(LLY.US)溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2449776517","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449776517?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:20","pubTimestamp":1720437619,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，为加强免疫学产品线，礼来周一宣布以每股57美元的价格现金收购生物制药公司Morphic Holding，或在交易完成时支付总计约32亿美元。交易宣布后，Morphic Holding股价盘前大涨近80%。根据协议，礼来将发起要约收购，以收购Morphic所有流通股。要约收购结束后，礼来将通过第二步合并，以相同的对价收购要约收购中未被收购的Morphic股份。此外，Morphic还在开发用于治疗自身免疫性疾病、肺动脉高压疾病、纤维化疾病和癌症的其他分子的临床前产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081923179590151c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081923179590151c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU2468319806.SGD","LU0385154629.USD","LU0689472784.USD","LU1623119135.USD","LU0943347566.SGD","LU0109391861.USD","LU0820561909.HKD","IE0002141913.USD","LU1712237335.SGD","IE00BJT1NW94.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU1057294990.SGD","LU1551013342.USD","LU2265009873.SGD","IE00B1BXHZ80.USD","LU0061475181.USD","LU1280957306.USD","LU2491049909.HKD","LU2237443978.SGD","LU2264538146.SGD","IE0004445239.USD","LU1804176565.USD","LU2237443622.USD","LU0256863811.USD","MORF","BK4139","LU1023059063.AUD","LU2491050071.SGD","BK4581","LU0079474960.USD","LU0466842654.USD","LLY","LU0058720904.USD","GB00BDT5M118.USD","LU0882574139.USD","LU1551013425.SGD","LU2237443382.USD","LU1988902786.USD","LU0122379950.USD","LU0097036916.USD","LU0882574055.USD","LU0820561818.USD","BK4585","LU2237443549.SGD","IE0009355771.USD","LU1814569148.SGD"],"gpt_icon":0},{"id":"2449776357","title":"【Morphic(MORF.US)盘前大涨近80% 获礼来(LLY.US)溢价收购】智通财经APP获悉，为加强免疫学产品线，礼来(LLY.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449776357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449776357?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:20","pubTimestamp":1720437619,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0289739699.SGD","LU0198837287.USD","LU1623119135.USD","LU0456855351.SGD","BK4139","LU0471298777.SGD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU0320765059.SGD","LU0882574139.USD","LU1280957306.USD","MORF","LU1712237335.SGD","BK4533","LU0708995401.HKD","LU0385154629.USD","LU0417517546.SGD","LU0820561818.USD","LU0820561909.HKD","LU0943347566.SGD","BK4581","LU1057294990.SGD","LU2237443382.USD","LU2237443622.USD","LU0640476718.USD","LU1814569148.SGD","LU1064131342.USD","LU2237438978.USD","BK4534","LU0466842654.USD","LU1267930730.SGD","LU2237443549.SGD","LU0097036916.USD","LU0672654240.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2265009873.SGD","BK4588","LU1988902786.USD","BK4585","LU1023059063.AUD","LU0689472784.USD","LU0061475181.USD","IE0009355771.USD","LU0114720955.EUR","LLY","LU2237443978.SGD","LU0238689110.USD","LU0109391861.USD"],"gpt_icon":0},{"id":"2449773948","title":"更新版 1-礼来以 32 亿美元收购肠道疾病药物开发商 Morphic","url":"https://stock-news.laohu8.com/highlight/detail?id=2449773948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449773948?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:58","pubTimestamp":1720436284,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (全文增加细节) 路透7月8日 - 礼来 和Morphic Holding 周一表示，两家公司将以32亿美元的价格收购Morphic Holding ，使这家美国制药商获得一种治疗炎症性肠病的实验性药物。由于礼来提出了每股57美元的收购价，药物开发商Morphic的股价盘前大涨76%，达到56.15美元，比该股上次收盘价溢价79%。 Morphic 公司的主打药物 MORF-057 正在溃疡性结肠炎患者的两项 2 期研究和克罗恩病的一项 2 期研究中进行评估。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","IE0009355771.USD","LU0097036916.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2491049909.HKD","LU0061475181.USD","LU0256863811.USD","LU1712237335.SGD","LU0943347566.SGD","LU2264538146.SGD","LU1623119135.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2237443978.SGD","LU0079474960.USD","BK4007","BK4533","LU0198837287.USD","LU0385154629.USD","LU0882574139.USD","LU2237443382.USD","LU2237443622.USD","IE00B1BXHZ80.USD","LLY","LU0109391861.USD","IE0004445239.USD","LU2265009873.SGD","LU1988902786.USD","BK4585","LU0820561818.USD","LU1280957306.USD","LU0708995401.HKD","LU0114720955.EUR","LU2237443549.SGD","LU2468319806.SGD","LU1057294990.SGD","LU0882574055.USD","LU1551013425.SGD","LU0820561909.HKD","LU0466842654.USD","IE00BJJMRZ35.SGD","LU1804176565.USD","MORF","LU1551013342.USD","IE0002141913.USD","BK4534","LU2491050071.SGD","GB00BDT5M118.USD","LU1064131342.USD"],"gpt_icon":0},{"id":"2449773990","title":"BUZZ-莫菲克控股公司因礼来公司收购交易而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2449773990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449773990?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:57","pubTimestamp":1720436248,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) 7月8日 - ** 药物开发商莫菲克控股公司 的股价盘前上涨59.8%至50.87美元** 礼来 表示将以每股57美元或约32亿美元现金的价格收购MORF (link) ** 莫菲克的主要资产是一种治疗炎症性肠病的药物** 截至上一交易日收盘，莫菲克股价年累计上涨 10.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1804176565.USD","LU0079474960.USD","LU2237443382.USD","LU1712237335.SGD","IE00BJJMRZ35.SGD","LU0097036916.USD","BK4533","IE00BFTCPJ56.SGD","LU1623119135.USD","LU0820561818.USD","LU0385154629.USD","LU1551013342.USD","LU0943347566.SGD","LU2264538146.SGD","LU0882574139.USD","LU0122379950.USD","LU0466842654.USD","IE00B1BXHZ80.USD","LU1551013425.SGD","BUZZ","LU0708995401.HKD","LLY","IE0004445239.USD","IE00BJT1NW94.SGD","LU1064131342.USD","BK4534","LU2265009873.SGD","LU2491050071.SGD","LU0058720904.USD","LU0820561909.HKD","BK4585","IE0002141913.USD","LU0882574055.USD","GB00BDT5M118.USD","LU0114720955.EUR","LU1057294990.SGD","LU2237443978.SGD","LU0689472784.USD","LU2237443622.USD","BK4007","LU2491049909.HKD","LU1988902786.USD","LU1280957306.USD","IE0009355771.USD","LU2468319806.SGD","LU0109391861.USD","MORF","LU0256863811.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"2449977806","title":"礼来公司将以 32 亿美元收购 Morphic 控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2449977806","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449977806?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:50","pubTimestamp":1720435817,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) 路透7月8日 - 礼来公司 和莫菲克公司 周一表示，将以32亿美元的价格收购莫菲克控股公司 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561909.HKD","LU0672654240.SGD","LU0109391861.USD","BK4585","LU2237443978.SGD","LU2237443382.USD","LU1057294990.SGD","MORF","IE00B1BXHZ80.USD","LU0882574055.USD","BK4588","LU0417517546.SGD","LU2491049909.HKD","IE0004445239.USD","LLY","IE00BJT1NW94.SGD","LU0061475181.USD","LU0079474960.USD","LU1023059063.AUD","LU0058720904.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU1988902786.USD","LU1551013342.USD","BK4581","BK4139","LU1623119135.USD","LU0943347566.SGD","LU1551013425.SGD","LU2237443622.USD","LU0708995401.HKD","LU0122379950.USD","LU0256863811.USD","LU0114720955.EUR","LU2237438978.USD","LU2491050071.SGD","IE0009355771.USD","LU1712237335.SGD","LU1280957306.USD","LU0097036916.USD","LU1804176565.USD","LU0385154629.USD","GB00BDT5M118.USD","IE0002141913.USD","BK4007","LU2237443549.SGD","LU2468319806.SGD","LU1814569148.SGD","LU2264538146.SGD","LU2265009873.SGD"],"gpt_icon":0},{"id":"1130714327","title":"将被礼来收购？生物制药公司Morphic盘前涨超75%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130714327","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130714327?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:49","pubTimestamp":1720435743,"startTime":"0","endTime":"0","summary":"7月8日，生物制药公司Morphic美股盘前涨超75%，报道称礼来将以57美元/股的价格现金收购Morphic。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU0097036916.USD","LU0672654240.SGD","LU0058720904.USD","LU0320765059.SGD","LU2264538146.SGD","LU0122379950.USD","LU2237443978.SGD","LU0198837287.USD","LU2237443622.USD","IE00B1BXHZ80.USD","LLY","LU2237438978.USD","LU2265009873.SGD","LU1280957306.USD","LU0882574055.USD","LU0820561909.HKD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","MORF"],"gpt_icon":0},{"id":"2448872912","title":"Morphic Holding, Inc.盘中异动 大幅下挫5.20%报32.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448872912","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448872912?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:22","pubTimestamp":1719847362,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时22分，Morphic Holding, Inc.股票出现异动，股价大幅跳水5.20%。截至发稿，该股报32.30美元/股，成交量11.573万股，换手率0.23%，振幅6.40%。Morphic Holding, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Morphic Holding, Inc.公司简介：Morphic Holding Inc是一家生物制药公司，将其对整合素的见解应用于发现和开发口服小分子整合素治疗药物的管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232242aef7702f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232242aef7702f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MORF"],"gpt_icon":0},{"id":"2446563214","title":"Morphic Holding, Inc.盘中异动 下午盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446563214","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446563214?lang=zh_cn&edition=full","pubTime":"2024-06-28 01:06","pubTimestamp":1719507965,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日01时06分，Morphic Holding, Inc.股票出现波动，股价大幅上涨5.02%。Morphic Holding, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2736.14%、374.02%、345.45%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为322.04%、127.05%、81.43%。Morphic Holding, Inc.公司简介：Morphic Holding Inc是一家生物制药公司，将其对整合素的见解应用于发现和开发口服小分子整合素治疗药物的管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628010605af8f8da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628010605af8f8da1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MORF"],"gpt_icon":0},{"id":"2446921793","title":"Morphic Holding, Inc.盘中异动 快速下挫5.22%报31.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446921793","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446921793?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:40","pubTimestamp":1719412809,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时40分，Morphic Holding, Inc.股票出现波动，股价快速跳水5.22%。截至发稿，该股报31.77美元/股，成交量15.1803万股，换手率0.30%，振幅4.06%。Morphic Holding, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Morphic Holding, Inc.公司简介：Morphic Holding Inc是一家生物制药公司，将其对整合素的见解应用于发现和开发口服小分子整合素治疗药物的管道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626224009968171b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626224009968171b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MORF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.morphictx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":1.0018},{"period":"1year","weight":0.9961},{"period":"ytd","weight":0.9733}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Morphic Holding, Inc.于2014年8月根据特拉华州法律成立。他们是一家生物制药公司，将其专有的见解应用于整合素，以发现和开发可能是一流的口服小分子整合素治疗药物。整合素是具有多种批准的可注射重磅炸弹药物的目标类别，用于治疗严重的慢性疾病，包括自身免疫，心血管和代谢疾病，纤维化和癌症。他们利用他们对整合素结构和生物学的独特理解，创建了Morphic整合素技术平台或MInT平台，以开发新的候选产品，旨在实现口服给药所需的效力，高选择性和药物性质。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.078197},{"month":2,"riseRate":0.6,"avgChangeRate":0.052974},{"month":3,"riseRate":0.4,"avgChangeRate":0.104852},{"month":4,"riseRate":0.2,"avgChangeRate":-0.08244},{"month":5,"riseRate":0.6,"avgChangeRate":0.104298},{"month":6,"riseRate":0.6,"avgChangeRate":0.101811},{"month":7,"riseRate":0.666667,"avgChangeRate":0.141303},{"month":8,"riseRate":0.666667,"avgChangeRate":0.017753},{"month":9,"riseRate":0.4,"avgChangeRate":-0.129239},{"month":10,"riseRate":0.2,"avgChangeRate":-0.073388},{"month":11,"riseRate":0.6,"avgChangeRate":0.060013},{"month":12,"riseRate":0.6,"avgChangeRate":0.066795}],"exchange":"NASDAQ","name":"Morphic Holding, Inc.","nameEN":"Morphic Holding, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Morphic Holding, Inc.(MORF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Morphic Holding, Inc.(MORF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Morphic Holding, Inc.,MORF,Morphic Holding, Inc.股票,Morphic Holding, Inc.股票老虎,Morphic Holding, Inc.股票老虎国际,Morphic Holding, Inc.行情,Morphic Holding, Inc.股票行情,Morphic Holding, Inc.股价,Morphic Holding, Inc.股市,Morphic Holding, Inc.股票价格,Morphic Holding, Inc.股票交易,Morphic Holding, Inc.股票购买,Morphic Holding, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Morphic Holding, Inc.(MORF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Morphic Holding, Inc.(MORF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}